N-[6-(1-aminoethyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methyl-1,2-thiazol-5-amine;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)benzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N-phenylbenzamide;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-5-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;N-(2-methylpropyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine
C115H117N45O3S3 — CID 158038761
Data last refreshed: (MolForge compound catalog, from PubChem)
IUPACN-[6-(1-aminoethyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methyl-1,2-thiazol-5-amine;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)benzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N-phenylbenzamide;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-5-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;N-(2-methylpropyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine
SMILESCC(C)CNc1nccn2c(-c3cnn(C)c3)cnc12.CN(C)C(=O)c1cccc(-c2cnc(N)c3nccn23)c1.Cc1cc(Nc2nc(C(C)N)cn3c(-c4cnn(C)c4)cnc23)sn1.Cc1cc(Nc2nc(C3=CCCNC3)cn3c(-c4cnn(C)c4)cnc23)sn1.Cc1cc(Nc2nc(C3=CCNCC3)cn3c(-c4cnn(C)c4)cnc23)sn1.NC(=O)c1cccc(-c2cnc(N)c3nccn23)c1.Nc1ncc(-c2cccc(C(=O)Nc3ccccc3)c2)n2ccnc12
InChIInChI=1S/2C19H20N8S.C19H15N5O.C16H18N8S.C15H15N5O.C14H18N6.C13H11N5O/c1-12-7-17(28-25-12)24-18-19-21-9-16(14-8-22-26(2)10-14)27(19)11-15(23-18)13-3-5-20-6-4-13;1-12-6-17(28-25-12)24-18-19-21-9-16(14-8-22-26(2)10-14)27(19)11-15(23-18)13-4-3-5-20-7-13;20-17-18-21-9-10-24(18)16(12-22-17)13-5-4-6-14(11-13)19(25)23-15-7-2-1-3-8-15;1-9-4-14(25-22-9)21-15-16-18-6-13(11-5-19-23(3)7-11)24(16)8-12(20-15)10(2)17;1-19(2)15(21)11-5-3-4-10(8-11)12-9-18-13(16)14-17-6-7-20(12)14;1-10(2)6-16-13-14-17-8-12(20(14)5-4-15-13)11-7-18-19(3)9-11;14-11-13-16-4-5-18(13)10(7-17-11)8-2-1-3-9(6-8)12(15)19/h3,7-11,20H,4-6H2,1-2H3,(H,23,24);4,6,8-11,20H,3,5,7H2,1-2H3,(H,23,24);1-12H,(H2,20,22)(H,23,25);4-8,10H,17H2,1-3H3,(H,20,21);3-9H,1-2H3,(H2,16,18);4-5,7-10H,6H2,1-3H3,(H,15,16);1-7H,(H2,14,17)(H2,15,19)
InChIKeyFIBZMGOOAJCETK-UHFFFAOYSA-N
MW2273.71 g/mol
LogP16.87
Rot. Bonds23
About N-[6-(1-aminoethyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methyl-1,2-thiazol-5-amine;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)benzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N-phenylbenzamide;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-5-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;N-(2-methylpropyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine
N-[6-(1-aminoethyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methyl-1,2-thiazol-5-amine;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)benzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N-phenylbenzamide;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-5-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;N-(2-methylpropyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine (PubChem CID 158038761) has the molecular formula C115H117N45O3S3 and a molecular weight of 2273.71 g/mol. Its IUPAC name is N-[6-(1-aminoethyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methyl-1,2-thiazol-5-amine;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)benzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N-phenylbenzamide;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-5-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;N-(2-methylpropyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine.
Molecular Properties
| Compound Name | N-[6-(1-aminoethyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methyl-1,2-thiazol-5-amine;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)benzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N-phenylbenzamide;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-5-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;N-(2-methylpropyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine |
|---|---|
| PubChem CID | 158038761 |
| Molecular Formula | C115H117N45O3S3 |
| Molecular Weight | 2273.71 g/mol |
| Exact Mass | 2271.95 |
| IUPAC Name | N-[6-(1-aminoethyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methyl-1,2-thiazol-5-amine;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)benzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N-phenylbenzamide;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-5-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;N-(2-methylpropyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine |
| SMILES | CC(C)CNc1nccn2c(-c3cnn(C)c3)cnc12.CN(C)C(=O)c1cccc(-c2cnc(N)c3nccn23)c1.Cc1cc(Nc2nc(C(C)N)cn3c(-c4cnn(C)c4)cnc23)sn1.Cc1cc(Nc2nc(C3=CCCNC3)cn3c(-c4cnn(C)c4)cnc23)sn1.Cc1cc(Nc2nc(C3=CCNCC3)cn3c(-c4cnn(C)c4)cnc23)sn1.NC(=O)c1cccc(-c2cnc(N)c3nccn23)c1.Nc1ncc(-c2cccc(C(=O)Nc3ccccc3)c2)n2ccnc12 |
| InChI | InChI=1S/2C19H20N8S.C19H15N5O.C16H18N8S.C15H15N5O.C14H18N6.C13H11N5O/c1-12-7-17(28-25-12)24-18-19-21-9-16(14-8-22-26(2)10-14)27(19)11-15(23-18)13-3-5-20-6-4-13;1-12-6-17(28-25-12)24-18-19-21-9-16(14-8-22-26(2)10-14)27(19)11-15(23-18)13-4-3-5-20-7-13;20-17-18-21-9-10-24(18)16(12-22-17)13-5-4-6-14(11-13)19(25)23-15-7-2-1-3-8-15;1-9-4-14(25-22-9)21-15-16-18-6-13(11-5-19-23(3)7-11)24(16)8-12(20-15)10(2)17;1-19(2)15(21)11-5-3-4-10(8-11)12-9-18-13(16)14-17-6-7-20(12)14;1-10(2)6-16-13-14-17-8-12(20(14)5-4-15-13)11-7-18-19(3)9-11;14-11-13-16-4-5-18(13)10(7-17-11)8-2-1-3-9(6-8)12(15)19/h3,7-11,20H,4-6H2,1-2H3,(H,23,24);4,6,8-11,20H,3,5,7H2,1-2H3,(H,23,24);1-12H,(H2,20,22)(H,23,25);4-8,10H,17H2,1-3H3,(H,20,21);3-9H,1-2H3,(H2,16,18);4-5,7-10H,6H2,1-3H3,(H,15,16);1-7H,(H2,14,17)(H2,15,19) |
| InChIKey | FIBZMGOOAJCETK-UHFFFAOYSA-N |
| XLogP | 16.87 |
| TPSA | 590.04 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 48 |
| Rotatable Bonds | 23 |
| Heavy Atoms | 166 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2273.71 |
| LogP ≤ 5 | 16.87 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 48 |
Frequently Asked Questions
What is the IUPAC name of N-[6-(1-aminoethyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methyl-1,2-thiazol-5-amine;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)benzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N-phenylbenzamide;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-5-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;N-(2-methylpropyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine?
The IUPAC name of N-[6-(1-aminoethyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methyl-1,2-thiazol-5-amine;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)benzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N-phenylbenzamide;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-5-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;N-(2-methylpropyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine (CID 158038761) is N-[6-(1-aminoethyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methyl-1,2-thiazol-5-amine;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)benzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N-phenylbenzamide;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-5-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;N-(2-methylpropyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine.
What is the SMILES notation for N-[6-(1-aminoethyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methyl-1,2-thiazol-5-amine;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)benzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N-phenylbenzamide;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-5-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;N-(2-methylpropyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine?
The canonical SMILES for N-[6-(1-aminoethyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methyl-1,2-thiazol-5-amine;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)benzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N-phenylbenzamide;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-5-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;N-(2-methylpropyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine is CC(C)CNc1nccn2c(-c3cnn(C)c3)cnc12.CN(C)C(=O)c1cccc(-c2cnc(N)c3nccn23)c1.Cc1cc(Nc2nc(C(C)N)cn3c(-c4cnn(C)c4)cnc23)sn1.Cc1cc(Nc2nc(C3=CCCNC3)cn3c(-c4cnn(C)c4)cnc23)sn1.Cc1cc(Nc2nc(C3=CCNCC3)cn3c(-c4cnn(C)c4)cnc23)sn1.NC(=O)c1cccc(-c2cnc(N)c3nccn23)c1.Nc1ncc(-c2cccc(C(=O)Nc3ccccc3)c2)n2ccnc12.
What is the InChIKey of N-[6-(1-aminoethyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methyl-1,2-thiazol-5-amine;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)benzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N-phenylbenzamide;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-5-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;N-(2-methylpropyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine?
The InChIKey is FIBZMGOOAJCETK-UHFFFAOYSA-N. The full InChI is InChI=1S/2C19H20N8S.C19H15N5O.C16H18N8S.C15H15N5O.C14H18N6.C13H11N5O/c1-12-7-17(28-25-12)24-18-19-21-9-16(14-8-22-26(2)10-14)27(19)11-15(23-18)13-3-5-20-6-4-13;1-12-6-17(28-25-12)24-18-19-21-9-16(14-8-22-26(2)10-14)27(19)11-15(23-18)13-4-3-5-20-7-13;20-17-18-21-9-10-24(18)16(12-22-17)13-5-4-6-14(11-13)19(25)23-15-7-2-1-3-8-15;1-9-4-14(25-22-9)21-15-16-18-6-13(11-5-19-23(3)7-11)24(16)8-12(20-15)10(2)17;1-19(2)15(21)11-5-3-4-10(8-11)12-9-18-13(16)14-17-6-7-20(12)14;1-10(2)6-16-13-14-17-8-12(20(14)5-4-15-13)11-7-18-19(3)9-11;14-11-13-16-4-5-18(13)10(7-17-11)8-2-1-3-9(6-8)12(15)19/h3,7-11,20H,4-6H2,1-2H3,(H,23,24);4,6,8-11,20H,3,5,7H2,1-2H3,(H,23,24);1-12H,(H2,20,22)(H,23,25);4-8,10H,17H2,1-3H3,(H,20,21);3-9H,1-2H3,(H2,16,18);4-5,7-10H,6H2,1-3H3,(H,15,16);1-7H,(H2,14,17)(H2,15,19).
What are the key properties of N-[6-(1-aminoethyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methyl-1,2-thiazol-5-amine;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)benzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N-phenylbenzamide;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-5-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;N-(2-methylpropyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine?
N-[6-(1-aminoethyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methyl-1,2-thiazol-5-amine;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)benzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N-phenylbenzamide;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-5-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;N-(2-methylpropyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine has a molecular weight of 2273.71 g/mol, XLogP of 16.87, 23 rotatable bonds, 12 hydrogen bond donors, and 48 hydrogen bond acceptors.
Where does this data come from?
All data for N-[6-(1-aminoethyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methyl-1,2-thiazol-5-amine;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)benzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-aminoimidazo[1,2-a]pyrazin-5-yl)-N-phenylbenzamide;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-methyl-N-[3-(1-methylpyrazol-4-yl)-6-(1,2,3,6-tetrahydropyridin-5-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;N-(2-methylpropyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine is sourced from PubChem (CID 158038761), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158038761 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.